Own Experience in Treatment of Autoimmune Goiter in the Last Decade

• Autorzy: Sławomir Rudzki , Mariusz Matuszek , Andrzej Nowakowski , Beata Matuszek , Przemysław Matras , Katarzyna Wojewoda
• Języki publikacji: EN

Abstrakty

EN

The aim of the study. The study was intended to be a retrospective analysis of clinical data concerning patients operated on for autoimmune goitre in the period 1998-2008, in the 1st Department of General and Transplant Surgery of the Medical University in Lublin.Material and methods. 1157 patients were operated on for various goitre forms. This group included 134 patients with Graves' and Hashimoto's disease associated goitre, which accounted for 11% of all goitre patients undergoing the surgery. Major indications to surgical treatment of the Graves' disease included progressive exophthalmos, goitre with compression symptoms, hoarseness, and uncertain biopsy diagnoses. As regards Hashimoto's disease, goitre with compression symptoms or with tumour-like changes, and ambiguous biopsy diagnoses were the factors qualifying the patient for surgical treatment. Statistical analysis was conducted using STATISTICA 6.0 PL software, the chi2 test was performed, and the statistical significance was established at p<0.005.Results. Graves' disease associated goitre was operated on in 72 patients, including 53 cases (39.5%) where infiltrative ophthalmopathy was also observed. Hashimoto's disease associated goitre was operated on in 62 patients. Early paralysis of the recurrent laryngeal nerve occurred in 10 (13.9%) patients operated on for Graves' disease, and in 5 (8.1%) patients operated on for Hashimoto's disease. As regards patients operated on for non-autoimmune goitre, early paralysis of the recurrent laryngeal nerve was observed in 29 (3%) cases. Post-surgical tetany was observed in 11.1% of Graves' disease patients, and in 8% of Hashimoto's disease patients. Finally, temporary post-surgical tetany was found in 2% of patients with non-autoimmune goitre.Conclusions. The type of goitre being operated on has a significant impact on the incidence of early post-surgical complications. In general, the incidence of early post-surgical complications is higher in the case of patients operated on for autoimmune-type goitre, compared with patients with non-autoimmune goitre. Yet this method is both safe and efficient. Total thyroid removal should be the treatment applied in the case of progressive orbitopathy associated with Graves' disease.

Słowa kluczowe

EN

autoimmune goitre; Graves' disease; Hashimoto's disease; total thyroid removal

• Wydawca: Index Copernicus International
• Czasopismo: Polish Journal of Surgery
• Rocznik: 2010
• Tom: 82
• Numer: 2
• Strony: 63-68

Daty

wydano

2010-02-01

online

2010-03-18

Twórcy

autor

Sławomir Rudzki

• 1 Department of General, Transplant Surgery and Immunal Nutrition, Medical University in Lublin

autor

Mariusz Matuszek

• 1 Department of General, Transplant Surgery and Immunal Nutrition, Medical University in Lublin

autor

Andrzej Nowakowski

• Department of Endocrinology, Medical University in Lublin

autor

Beata Matuszek

• Department of Endocrinology, Medical University in Lublin

autor

Przemysław Matras

• 1 Department of General, Transplant Surgery and Immunal Nutrition, Medical University in Lublin

autor

Katarzyna Wojewoda

• 1 Department of General, Transplant Surgery and Immunal Nutrition, Medical University in Lublin

Bibliografia

• Volpe R: Autoimmune thyroiditis (w) Thyroid Function and Disease red. Burrow, Oppenheimer, Volpe, W. B. Saunders Company, Philadelphia 1990.
• Dayan CM, Daniels GH: Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99-106.
• Akamizu T: Antithyrotropin receptor antibody: an update. Thyroid 2001; 12: 1123-34.[Crossref]
• Davies T, Marians R, Latif R: The TSH receptor reveals itself. J Clin Invest 2002; 110: 161-64.[PubMed]
• Paschke R, Eck T, Herfurth J, Usadel KHP: Stimulation of proliferation and inhibition of function of xenotrasplanted human thyroid tissue by epidermal growth factor. J Endocrinol Invest 1995; 18: 359-63.
• Witte J, Goretzki PE, Dotzenrath C et al.: Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg 2000; 24(11): 1303-11.[Crossref]
• Gimm O, Brauckhoff M, Thanh PN et al.: An update on thyroid surgery. Eur J Nuclear Med 2002; (29): 447-52.[Crossref]
• Narębski JM, Pomorski L, Czyż W: Zapalenia tarczycy a leczenie operacyjne. Pol Przegl Chir 1996; 10: 1015-19.
• Krzętowski A, Brzozowska M, Kinalska I: Ocena występowania zaburzeń autoimmunologicznych tarczycy u dzieci w populacji Białegostoku. Wiad Lek 2006; 59: 639-43.
• Paluszkiewicz R, Krawczyk M, Frączek M i wsp.: Wczesne powikłania leczenia chirurgicznego wola tarczycy. Chir Pol 2002; 4, 1: 27-31.
• Kozicki I, Durowicz S: "Anatomiczne" całkowite usunięcie tarczycy w materiale własnym - ocena prospektywna powikłań po operacji raka i chorób nienowotworowych. Postępy Nauk Medycznych 2009; 3: 167-72.
• Doufas AG, Mastorakos G, Chatiioannou S et al.: The predominant form of non-toxic goiter in Greece is now autoimmune thyroiditis. Eur J Endocrinol 1999; 140: 505-11.
• Loviselli A, Velluzzi F, Mossa P et al.: The Sardinian autoimmunitystudy: Studies on circulating anthityroid antibodies in Sardinian schoolchildren: relationship to goiter prevalence and thyroid function. Thyroid 2001; 11,9: 849-57.[Crossref]
• Boostrom S, Richards ML: Total thyroidectomy is the preferred treatment for patients with Graves' disease and a thyroid nodule. Otolaryngol Head Neck Surg 2007; 136(2): 278-81.
• Barakate MS, Agarwal G, Reeve TS et al.: Total thyroidectomy is now the preferred option for the surgical management of Graves' disease. ANZ J Surg 2002; 72,5: 321-24.[Crossref]
• Ian R, Gough MD, David Wilkinson MB: Total Thyroidectomy for Management of Thyroid Disease. Worl J Surg 2000; 24: 926-65.
• Lal G, Ituarte P, Kebebew E et al.: Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease? Thyroid 2005; 15,6: 569-74.[Crossref]
• Kuzdak K, Brzeziński J, Kołomecki K i wsp.: Pomorski Lech - Chirurgia endokrynologiczna. Med Prakt Chir 2006; 65,1: 104-10.
• Pomorski L, Kuzdak K, Bartos M i wsp.: Nawroty raka tarczycy - postępowanie chirurgiczne oparte na materiale własnym. Onkol Pol 1999; 2(1): 25-28.
• Greenspan FS, Gardner DG: The thyroid gland. W: Basic and Clinical Endocrinology. Red. Greenspan FS, Gardner DG. 6th edition. McGraw-Hill. Nowy Jork 2001; 257258.
• Barczyński M, Cichoń S, Anielski R i wsp.: Częstość występowania niedoczynności przytarczyc po operacji wola - profilaktyka i leczenie. Pol Przegl Chir 1996; 68(2): 133-38.
• Kozera JW, Starzewski J, Widala E i wsp.: Analiza uszkodzeń nerwów krtaniowych wstecznych w zależności od rodzaju wola i techniki operacyjnej. Pol Przegl Chir 1998; 70(10): 1007-16.
• Skrzypek J, Podwiński A: Powikłania śródoperacyjne i zapobieganie im w czasie leczenia chirurgicznego wola. Pol Przegl Chir 1991; 63(11): 981-85.

Identyfikatory

DOI

10.2478/v10035-010-0011-3